ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 716-721

  Zalcberg, J R ^a   Cunningham, D ^a   Van Cutsem, E ^a   Francois, E ^a   Schornagel, J ^a   Adenis, A ^a   Green, M ^a   Iveson, A ^a   Azab, M ^a   Seymour, I ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIEMETIC AGENT; IRINOTECAN; RALTITREXED;

ADULT; ADVANCED CANCER; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASTHENIA; CANCER INHIBITION; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 9044245305     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.716     Document Type: Article

References (18)

1. Chu CK, Tarone RE, Chow W-H, et al: Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 86:999-1006, 1994
2. Poon MA, O'Connell MJ, Moertel CG, et al: Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7:1407-1418, 1989
3. Sotos AG, Grogan L, Allegra CJ: Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat Rev 20:11-49, 1994
4. The Advanced Colorectal Cancer Meta-Analysis Project: Meta-analysis of randomised trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12:960-969, 1994
5. The Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992
6. Scheithauer W, Depisch D, Kornek G, et al: Randomised comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin and cisplatinum therapy in patients with advanced colorectal cancer. Cancer 73:1562-1568, 1994
7. R) in metastatic colorectal carcinoma. Ann Oncol 5:468-470, 1994
8. Shimada Y, Yoshino M, Waku A, et al: Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. J Clin Oncol 11:909-913, 1993
9. Jackman AL, Gibson W, Brown M, et al: The role of the reduced-folate carrier and metabolism to intracellular polyglutamates for the activity of ICI D1694, in Rustum YM (ed): Novel Approaches to Selective Treatments of Human Solid Tumours: Laboratory and Clinical Correlation. New York, NY, Plenum, 1993, pp 265-276
10. Judson I, Clarke S, Ward J, et al: A Phase I trial of the thymidylate synthase inhibitor ICI D1694. Ann Oncol 3:51, 1992 (suppl 5; abstr)
11. Sorensen JM, Jordan E, Green JL, et al: Phase I trial of ZD1694 ('Tomudex'), a direct inhibitor of thymidylate synthase. Ann Oncol 5:1994 (suppl 5; abstr)
12. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva, Switzerland, World Health Organization, 1979
13. Hayward JL, Carbone PP, Henson JC, et al: Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13:89-94, 1977
14. Wittes RE (ed): Manual of Therapeutic Oncology. Philadelphia, PA, Lippincott, 1989/1990
15. Buroker TR, O'Connell MJ, Wieand HS, et al: Randomised comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14-20, 1994
16. Poon MA, O'Connell MJ, Wieand HS, et al: Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9:1967-1972, 1993
17. Clarke SJ, Jackman AL, Judson IR: The history of the development and clinical use of CB3717 and ICI D1694, in YM Rustum (ed): Novel Approaches to Selective Treatments of Human Solid Tumours: Laboratory and Clinical Correlation. New York, NY, Plenum, 1993, pp 277-287
18. Jackman AL, Farrugia DC, Clarke SJ, et al: Delayed rescue of ZD1694 toxicity in Balb/c mice with thymidine (dThd) or leucovorin. Proc Am Assoc Cancer Res 36:377, 1995 (abstr 2246)